/d10o6nnig0wrdw.cloudfront.net/09-26-2024/t_0362e9cb99ef4d6aad790009f190d692_name_file_960x540_1600_v4_.jpg)
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks
Plus, how the industry plans to offset looming patent losses and where to find top stocks.
Markets
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/AGAGH4NDF5FCRKXQANXPYS6TBQ.png "Bonds collage hero")
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/NPR5K52H6ZFOBAXCTPCEOIQTM4.png)
Funds
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/OMVK3XQEVFDRHGPHSQPIBDENQE.jpg "Mutual Funds hero")
Stocks
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/SIYOLFGHKJFSTPDA2FV7U4GUDE.png "Line bar graph coins green hero")
Get the best of Morningstar straight to your inbox
Market Insights
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/PNCGQ5M56VGC5PJRBI7FPQIR7E.png "Markets Outlook Yellow")
Market News
- Paul Bilzerian avoided a $180 million fine for over 30 years. The SEC may have finally caught up.
- Utilities Hit All-Time Highs After Inflation Data — Utilities Roundup
- Communications Services Up Amid Deal Activity — Communications Services Roundup
- Tech Down as Traders Rotate Out of Sector — Tech Roundup
- Financials Up as Money Managers Gain on Strong Markets — Financials Roundup
Company Reports
- THOThor Industries Inc
Thor Looks Well Set Up to Remain the Top RV Firm in an Oligopolistic Space
/author-service-images-prod-us-east-1.publishing.aws.arc.pub/morningstar/222a1c0d-911c-4064-ac93-f9d4516d0a06.jpg)
- Rating
- Price
- $108.42
- Fair Value
- $478.00
- Uncertainty
- Very High
- Economic Moat
- Rmdk
- Capital Allocation
- Kqzwbwcv
- LAACLithium Americas (Argentina) Corp
Lithium Argentina Should Benefit From Strong Demand as Its First Project Ramps Up Production
/author-service-images-prod-us-east-1.publishing.aws.arc.pub/morningstar/ca8d2ce1-cd0f-433b-a52b-d163be882398.jpg)
- Rating
- Price
- $3.28
- Fair Value
- $97.00
- Uncertainty
- Very High
- Economic Moat
- Khtwpm
- Capital Allocation
- Yfrgxrz
- LLYEli Lilly and Co
Eli Lilly's Cardiometabolic Portfolio and Pipeline Support Strong Growth and a Wide Moat
/author-service-images-prod-us-east-1.publishing.aws.arc.pub/morningstar/558ccc7b-2d37-4a8c-babf-feca8e10da32.jpg)
- Rating
- Price
- $909.32
- Fair Value
- $542.00
- Uncertainty
- High
- Economic Moat
- Qvf
- Capital Allocation
- Gbxxjcfmny
- PFEPfizer Inc
Pfizer's Diverse Portfolio of Drugs and Vaccines Supports a Wide Moat
- Rating
- Price
- $28.97
- Fair Value
- $18.00
- Uncertainty
- Medium
- Economic Moat
- Vccnl
- Capital Allocation
- Dqcdkxcl
- MRKMerck & Co Inc
Merck's Wide Moat Is Supported by Leading Oncology Drug Keytruda and a Growing Pipeline
- Rating
- Price
- $113.09
- Fair Value
- $669.00
- Uncertainty
- Medium
- Economic Moat
- Vbd
- Capital Allocation
- Jkytrmjc
- BMYBristol-Myers Squibb Co
Bristol's Growing Portfolio and Pipeline Partly Offset Headwinds From Generic Competition
- Rating
- Price
- $50.12
- Fair Value
- $49.00
- Uncertainty
- Medium
- Economic Moat
- Qhl
- Capital Allocation
- Chbchkvgf
- ABBVAbbVie Inc
Wide-Moat AbbVie Poised for Growth, Driven by Innovation in Immunology Beyond Humira
- Rating
- Price
- $191.90
- Fair Value
- $323.00
- Uncertainty
- High
- Economic Moat
- Pcsh
- Capital Allocation
- Dxyrtmd
- JNJJohnson & Johnson
J&J's Diversified Pharma and Device Businesses Support a Solid Wide Moat
- Rating
- Price
- $161.39
- Fair Value
- $438.00
- Uncertainty
- Low
- Economic Moat
- Glqc
- Capital Allocation
- Qbgyfdjg
- UBIUbisoft Entertainment
Weak Execution Has Overshadowed the Value of Ubisoft's Core Franchises
/author-service-images-prod-us-east-1.publishing.aws.arc.pub/morningstar/12c6871b-2322-44d8-bd98-0437fa1a0a07.jpg)
- Rating
- Price
- €10.52
- Fair Value
- €83.00
- Uncertainty
- High
- Economic Moat
- Vhzyww
- Capital Allocation
- Hmxrjlgj
- KNEBVKONE Oyj Class B
Kone Primes Itself for Service and Modernization Growth to Offset Weak China New Equipment Orders
- Rating
- Price
- €53.62
- Fair Value
- €52.00
- Uncertainty
- Low
- Economic Moat
- Twqg
- Capital Allocation
- Xstvcvjy
- 8697Japan Exchange Group Inc
Japan Exchange's Underlying Results Continue to Be Strong Due to Yen Depreciation
- Rating
- Price
- ¥1,909.00
- Fair Value
- ¥6,173.00
- Uncertainty
- Medium
- Economic Moat
- Njq
- Capital Allocation
- Qvxjkrrm
- 00017New World Development Co Ltd
New World Development's Margin Squeezed by Weak Property Prices Before Home Market Bottoms
- Rating
- Price
- HK$9.96
- Fair Value
- HK$3.60
- Uncertainty
- Medium
- Economic Moat
- Mkbg
- Capital Allocation
- Krlvcdfdv
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/6ZMXY4RCRNEADPDWYQVTTWALWM.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/FPI4DOPK5VFUNIOGY5CVTI6NCI.png)
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/SRXFRUTTFZGPPK6U6Y5EG4WGMY.png)
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/T6LOA5ZYUZEWPLNEAQHTZASGTY.png)
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/GQNJPRNPINBIJGIQBSKECS3VNQ.jpg "Financial Education Hero")
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/MNPB4CP64NCNLA3MTELE3ISLRY.jpg)
United States